Oil Slides More Than 3% as Trump Downplays Prospect of New Iran Strikes

Zura Bio’s tibulizumab fails phase 2 trial for skin disease

Investing.com · News 10m ago

Atea Pharmaceuticals secures $200M credit facility from Hercules

Investing.com · News 10m ago

Spruce Biosciences plans spinoff of CAH drug program

Investing.com · News 10m ago

Can-Fite reports patient cancer-free 10 years after trial

Investing.com · News 10m ago

Crisis mundial del vino obliga a los viñedos chilenos a reinventar sus negocios

Bloomberg · Markets Video 10m ago

Faeth reports phase 2 trial results for endometrial cancer drug

Investing.com · News 10m ago

Brady adds two directors to board, one retires

Investing.com · News 10m ago

Basic Materials Roundup: Market Talk

Dow Jones · Markets 10m ago

Affiliated Managers earnings beat by $0.71, revenue fell short of estimates

Investing.com · News 10m ago

Top 3 stocks to buy this week: Union Bank, Ather Energy, Laurus Labs by market expert; check stop-loss, target price

LiveMint · Markets 12m ago